Companies Directory

MTR, founded in 2018, is an early stage company developing a new class of radiopharmaceuticals for Dx and Tx of solid tumors utilizing the overexpression of PARP-1 in tumor tissue. PARP is located on the DNA itself making PARP an ideal target for radionuclide based precision medicine. The precisely targeting of tumors with a radiolabeled PARP inhibitor offers both an unique diagnostic & staging potential and highly efficient & precisely targeted tumor therapy with minimal side effects. There continues to be a high unmet medical need for a potent anti-cancer therapy that includes efficacy against tumors that are currently poorly treatable or show multi-drug resistance. The MTR technology is deeply rooted in the theranostics principle in molecular medicine combining both diagnostic imaging and therapy with the same molecule being radiolabeled differently. This integrated companion approach deposits a highly targeted lethal payload to tumor tissue addressing even small therapy-resistant refractory lesions without systemic toxicity. Result: A new generation of targeted cancer Dx & Tx in a novel approach.

Molecular Vista, Inc. develops nanochemical spatial mapping tools that probe and analyze matter at the molecular level through quantitative visualization. Its flagship product, Vista One, combines atomic force microscopy (AFM) and IR spectroscopy to acquire both topography and chemical signature(s) at the nanometer scale. Through its patented technique of Photo-induced Force Microscopy (PiFM), the photo-induced polarization of the sample is measured directly in the near-field by detecting the time-integrated force between the tip and the sample. PiFM demonstrates exceptional spatial resolution (~5 nm), excellent sensitivity (monolayer), a good correlation to bulk FTIR spectra, and universal applicability to a wide range of organic and inorganic materials. By imaging infrared wavelengths specific to different chemical entities, PiFM can resolve the nanometer-scale distribution of each chemical species in diverse multi-phase and multi-component systems, thereby revealing an unprecedented and spectacular molecular vista to the researcher. The Vista One can be equipped with scattering SNOM, Raman, or other options as well. Molecular Vista was founded by two industry veterans, H. Kumar Wickramasinghe, Ph.D., and Sung Park, Ph.D. (co-founder of Park Scientific Instruments).

Creating a world where most diseases are prevented, by giving people the power of molecular diagnostics

MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMDs assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Brian Druker, director of the Knight Cancer Center at Oregon Health & Science University and lead clinical investigator for Gleevec, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation and Upstate Biotechnology.

Molecule is a Marketing and Content Production Company .Based in Mumbai and New york . We have our own Intellectual properties in Cinema ,Women Empowerment ,Fashion and Sports.

We are Moledro Digital, a digital consultancy with unique experience advising clients across the entertainment, FMCG and professional services industries. We create connections for our clients that resonate with their customers and audiences. We do this by telling engaging stories and creating meaningful and shareable digital experiences.

A Molegolar projeta edifícios residenciais resilientes, de alta eficiência, compostos por módulos flexíveis que podem funcionar como unidades independentes ou podem ser combinados para formar apartamentos de vários tamanhos diferentes em qualquer andar, a qualquer momento. Essa abordagem permite que as incorporadoras moldem sua oferta de acordo com o que a demanda deseja em termos de espaço, resultando em um mercado-alvo mais amplo, acelerando as vendas e reduzindo os riscos de investimento. O processo é reversível para que os apartamentos possam se adaptar às necessidades de espaço e à situação financeira do usuário ao longo da vida, expandindo ou reduzindo sua moradia ao anexar ou destacar módulos. Essa nova abordagem também traz novos argumentos de vendas, permite execuções hipotecárias parciais e é ecológica, uma vez que otimiza áreas construídas nas cidades pela possibilidade de reutilização de espaços ociosos, promovendo adensamento, entre outros ganhos ambientais e benefícios sociais.

molemab S.p.A. is an Italian leading company in the manufacturing industry of abrasive tools, grinding wheels, cutting and snagging wheels. Since 1961 Molemab S.p.A. has led the way by bringing its main assets of quality, innovation and service in the world. Headquarter located in Ome, Brescia in northern Italy, Molemab is a family-owned company supported by a team of professional and prepared people. During the years Molemab opened two subsidiaries, one in Launsdorf (Austria) and one in Oswego (Illinois, U.S.), and other 10 branches between commercial and technical hubs supporting the local customers. Our mission is to design and produce grinding wheels on the request of our customers and provide the best after-sales assistance. Molemab: we shape your world since 1961.